The bill, H.B. No. 4813, amends the Health and Safety Code regarding the scheduling of controlled substances in Texas, specifically in response to actions taken by the United States Food and Drug Administration (FDA). Key changes include the addition of Subsection (g-1), which stipulates that if a controlled substance listed in Schedule I is approved by the FDA and subsequently deleted or rescheduled under federal law, the Texas commissioner must also delete or reschedule that substance accordingly. This process must occur as soon as practicable after the commissioner receives notice of the federal action.

Additionally, the bill modifies existing subsections to clarify the commissioner’s authority in establishing and altering schedules of controlled substances. It emphasizes that any changes to the schedules must align with federal modifications and require the approval of the executive commissioner, except for alterations mandated by the new Subsection (g-1). The changes will only apply to controlled substances that are deleted or rescheduled under federal law after the bill's effective date of September 1, 2025.

Statutes affected:
Introduced: Health and Safety Code 481.034 (Health and Safety Code 481)